"Virginia Eye Consultants is an eye care center and ophthalmology clinic that has been providing comprehensive eye care to patients in Norfolk, Hampton, Suffolk, and Virginia Beach for over 55 years. Our experienced ophthalmologists and optometrists are committed to enhancing vision with state-of-the-art technology and personalized care. We specialize in vision correction procedures, including LASIK, PRK, and RLE. Our eye doctors and retina specialists also offer treatment for glaucoma, cataracts, retinal diseases including diabetic retinopathy, presbyopia, and dry eyes. Additionally, we provide aesthetic treatments including eyelid surgery (blepharoplasty) and non-surgical rejuvenation such as BOTOX® Cosmetic."

During the past decade, Virginia Eye Consultants conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 17 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Eye Consultants" #1 sponsor was "Lux Biosciences, Inc." with 5 trials, followed by "Aerie Pharmaceuticals" with 4 trials sponsored, "Eyegate Pharmaceuticals, Inc." with 4 trials sponsored, "Kala Pharmaceuticals, Inc." with 4 trials sponsored and "Ionis Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Eye Consultants" #1 collaborator was "Baylor College of Medicine" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "ScienceBased Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Eye Consultants" are "Panuveitis" (6 trials), "Uveitis, Intermediate" (5 trials), "Uveitis, Posterior" (5 trials), "Dry Eye" (4 trials) and "Keratoconjunctivitis Sicca" (4 trials). Many other conditions were trialed in "Virginia Eye Consultants" in a lesser frequency.

Most popular intervention types in "Virginia Eye Consultants" are "Drug" (36 trials), "Device" (5 trials), "Other" (4 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Fomivirsen sodium" (3 trials), "LX211" (3 trials), "KPI-121 0.25% Ophthalmic Suspension" (2 trials) and "LX201" (2 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Eye Consultants" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Eye Consultants". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Virginia Eye Consultants, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Eye Consultants, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".